Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ostermann

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|May 1, 1988
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarctionC Diefenbach, R Erbel, T Pop, et al.
International Journal of Hematology|October 7, 2008
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicityL H Lindner, H Ostermann, W Hiddemann, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Atherosclerosis|July 31, 1999
Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteriesM B Steins, T Padró, C X Li, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJ Kienast, M Juers, C J Wiedermann, et al.
Mycoses|April 5, 2012
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitalsC T Rieger, O A Cornely, T Hoppe-Tichy, et al.
Bone Marrow Transplantation|April 1, 1997
Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedureU Cassens, P Ostkamp-Ostermann, H Garritsen, et al.
Mycoses|May 11, 2011
Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009M Karthaus, M J G T Rüping, O A Cornely, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|May 1, 1988
Recombinant single-chain urokinase-type plasminogen activator during acute myocardial infarctionC Diefenbach, R Erbel, T Pop, et al.
International Journal of Hematology|October 7, 2008
AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicityL H Lindner, H Ostermann, W Hiddemann, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Atherosclerosis|July 31, 1999
Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteriesM B Steins, T Padró, C X Li, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulationJ Kienast, M Juers, C J Wiedermann, et al.
Mycoses|April 5, 2012
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitalsC T Rieger, O A Cornely, T Hoppe-Tichy, et al.
Bone Marrow Transplantation|April 1, 1997
Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedureU Cassens, P Ostkamp-Ostermann, H Garritsen, et al.
Mycoses|May 11, 2011
Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009M Karthaus, M J G T Rüping, O A Cornely, et al.
Pageof 7